Structure-Property Relationship for Different Mesoporous Silica Nanoparticles and its Drug Delivery Applications: A Review
- PMID: 35372272
- PMCID: PMC8964429
- DOI: 10.3389/fchem.2022.823785
Structure-Property Relationship for Different Mesoporous Silica Nanoparticles and its Drug Delivery Applications: A Review
Abstract
Mesoporous silica nanoparticles (MSNs) are widely used as a promising candidate for drug delivery applications due to silica's favorable biocompatibility, thermal stability, and chemical properties. Silica's unique mesoporous structure allows for effective drug loading and controlled release at the target site. In this review, we have discussed various methods of MSNs' mechanism, properties, and its drug delivery applications. As a result, we came to the conclusion that more in vivo biocompatibility studies, toxicity studies, bio-distribution studies and clinical research are essential for MSN advancement.
Keywords: drug delivery; mesoporous; nanoparticles; properties; silica.
Copyright © 2022 Kazemzadeh, Sayadi, Toolabi, Sayadi, Zeraati, Chauhan and Sargazi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Mesoporous silica nanoparticles in target drug delivery system: A review.Int J Pharm Investig. 2015 Jul-Sep;5(3):124-33. doi: 10.4103/2230-973X.160844. Int J Pharm Investig. 2015. PMID: 26258053 Free PMC article. Review.
-
Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.Acta Biomater. 2021 Oct 15;134:576-592. doi: 10.1016/j.actbio.2021.07.023. Epub 2021 Jul 17. Acta Biomater. 2021. PMID: 34280558
-
Mesoporous silica nanoparticles in drug delivery and biomedical applications.Nanomedicine. 2015 Feb;11(2):313-27. doi: 10.1016/j.nano.2014.09.014. Epub 2014 Nov 13. Nanomedicine. 2015. PMID: 25461284 Review.
-
Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.Curr Pharm Des. 2022;28(2):151-164. doi: 10.2174/1381612827666211111152839. Curr Pharm Des. 2022. PMID: 34766889 Review.
-
Silica-based mesoporous nanoparticles for controlled drug delivery.J Tissue Eng. 2013 Sep 3;4:2041731413503357. doi: 10.1177/2041731413503357. eCollection 2013. J Tissue Eng. 2013. PMID: 24020012 Free PMC article.
Cited by
-
Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica.Pharmaceutics. 2023 Feb 16;15(2):660. doi: 10.3390/pharmaceutics15020660. Pharmaceutics. 2023. PMID: 36839982 Free PMC article.
-
Three Different Interaction Patterns between MCM-41 and Proteins.Int J Mol Sci. 2022 Dec 13;23(24):15850. doi: 10.3390/ijms232415850. Int J Mol Sci. 2022. PMID: 36555490 Free PMC article.
-
Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate.Materials (Basel). 2023 Apr 26;16(9):3379. doi: 10.3390/ma16093379. Materials (Basel). 2023. PMID: 37176259 Free PMC article.
-
Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.Pharm Nanotechnol. 2024;12(3):269-275. doi: 10.2174/2211738511666230818092706. Pharm Nanotechnol. 2024. PMID: 37594097
-
RNA Structure: Past, Future, and Gene Therapy Applications.Int J Mol Sci. 2024 Dec 26;26(1):110. doi: 10.3390/ijms26010110. Int J Mol Sci. 2024. PMID: 39795966 Free PMC article. Review.
References
-
- Aiello R., Cavallaro G., Giammona G., Pasqua L., Pierro P., Testa F. (2002). “Mesoporous Silicate as Matrix for Drug Delivery Systems of Non-steroidal Antinflammatory Drugs,” in Studies in Surface Science and Catalysis (Elsevier; ), 1165–1172. 10.1016/s0167-2991(02)80276-2 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous